Compound information
- Natural Products
- ZC231357
- Molecular Formula
- C19H28N4O5
- Molecular Weight
- 392.205969996 g/mol
- Structure
-
- IUPAC Name
- benzyl N-[2-[[(1S)-2-[[(1S,2S)-1-carbamoyl-2-methyl-butyl]amino]-1-methyl-2-oxo-ethyl]amino]-2-oxo-ethyl]carbamate
- InChI
- InChI=1S/C19H28N4O5/c1-4-12(2)16(17(20)25)23-18(26)13(3)22-15(24)10-21-19(27)28-11-14-8-6-5-7-9-14/h5-9,12-13,16H,4,10-11H2,1-3H3,(H2,20,25)(H,21,27)(H,22,24)(H,23,26)/t12-,13-,16-/m0/s1
- InChI Key
- ZJNITTSQIVIBPV-XEZPLFJOSA-N
- SMILES
- CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)CNC(=O)OCc1ccccc1)C(N)=O
- Source
- ZINC000101220192
Warheads
- Carbamate
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 28 | Ring Count | 1 |
Heteroatom Count | 9 | Rotatable Bond Count | 10 |
Hydrogen Bond Acceptor Count | 5 | Hydrogen Bond Donor Count | 4 |
Topological Polar Surface Area | 139.62 Å2 | LogP | 1.13 |
LogS | -2.759 | LogD | 1.664 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.0 | Pgp substrate | 0.31 |
HIA | 0.477 | F20 % | 0.988 |
F30 % | 0.005 | Caco-2 | -6.423 |
MDCK | -5.569 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.147 | PPB | 79.838 |
VD | 0.513 | Fu | 0.682 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.002 | CYP1A2 substrate | 0.619 |
CYP2A6 substrate | 0.444 | CYP2B6 substrate | 0.594 |
CYP2C19 inhibitor | 0.183 | CYP2C19 substrate | 0.965 |
CYP2C8 substrate | 0.778 | CYP2C9 inhibitor | 0.003 |
CYP2C9 substrate | 0.999 | CYP2D6 inhibitor | 0.018 |
CYP2D6 substrate | 0.798 | CYP2E1 substrate | 0.222 |
CYP3A4 inhibitor | 0.036 | CYP3A4 substrate | 1.0 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.724 | CL | 4.899 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.019 | Hepatotoxicity | 0.08 |
Mutagenicity | 0.005 | Rat Oral Acute Toxicity | 0.086 |
FDAMDD | 0.051 | Skin Sensitization | 0.0 |
Carcinogenicity | 0.009 | Eye Corrosion | 0.009 |
Eye Irritation | 0.007 | Respiratory Toxicity | 0.011 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | -0.771 | IGC50 | 1.674 |
LC50FM | 2.778 | LC50DM | 4.939 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.13 | NR-AR-LBD | 0.305 |
NR-AhR | 0.002 | NR-Aromatase | 0.054 |
NR-ER | 0.334 | NR-ER-LBD | 0.363 |
NR-PPAR-gamma | 0.309 | SR-ARE | 0.226 |
SR-ATAD5 | 0.33 | SR-HSE | 0.172 |
SR-MMP | 0.009 | SR-p53 | 0.024 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.